Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesMedistim ASA

Medistim ASA

PortfolioPortfolio WatchlistWatchlist
Company price
306.0 GBX 6.00 ( 2.00%)
Last update at 2026-10-26T08:11:00Z
Market Cap
4293.81M
P/E
0.44

Momentum Score

…

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
301.00
Low
306.00
High
52 Week Price Range
154.88
Low
288.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
300.00
Dividend Yield
3.62%
Revenue TTM
699.77M
Revenue Per Share
38.29
Gross Profit TTM
571.59M
Debt / Equity
0.16
ROE
35.18%
Net Debt
-137.09M
ROCE
37.92%
Diluted EPS TTM
5.08

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 206.85M 134.25M 135.21M 146.05M 114.07M
Net income 159.21M 103.83M 103.82M 113.97M 90.90M
Selling general administrative - 164.47M 63.12M 130.60M 121.10M
Selling and marketing expenses - 9.88M 6.39M 5.91M 2.92M
Gross profit 319.06M 235.39M 224.70M 379.78M 320.70M
Ebit 196.20M 134.71M 135.78M 141.25M 110.99M
Ebitda 221.03M 159.22M 159.44M 157.45M 127.26M
Depreciation and amortization 24.83M 24.51M 23.66M 16.20M 16.27M
Operating income 196.20M 124.64M 126.19M 141.25M 110.99M
Other operating expenses 503.57M 431.52M 394.92M 341.01M 303.58M
Interest expense 6.37M 0.46M 0.50M - 0.00M
Income tax expense 47.64M 30.41M 31.39M 32.08M 23.17M
Total revenue 699.77M 556.16M 521.11M 486.26M 417.82M
Total operating expenses 122.86M 110.75M 98.51M 234.52M 206.47M
Cost of revenue 380.71M 320.77M 296.41M 106.48M 97.11M
Total other income expense net 10.65M 9.61M 9.02M 4.80M 3.08M
Net income applicable to common shares - - - 113.97M 90.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 660.60M 574.97M 505.72M 482.66M 403.24M
Intangible assets 71.97M 45.21M 31.25M 21.94M 16.04M
Other current assets 0.00M 5.63M 18.00M 17.26M 10.96M
Total liab 192.19M 138.36M 107.78M 114.97M 97.19M
Total stockholder equity 468.41M 436.61M 397.94M 367.69M 306.05M
Other current liab 143.21M 71.03M -4.38M 75.35M 64.40M
Common stock 4.58M 4.58M 4.58M 4.58M 4.58M
Retained earnings - 328.80M 307.38M 285.35M 240.16M
Other liab - - - 5.12M 2.51M
Good will 14.13M 14.13M 14.13M 14.13M 14.13M
Other assets - - - 9.38M 7.71M
Cash 212.09M 179.21M 153.87M 152.64M 129.49M
Total current liabilities 143.21M 107.37M 94.28M 99.82M 77.60M
Current deferred revenue - - 28.40M - -
Net debt -137.09M -144.85M -136.23M -152.64M -129.49M
Short term debt - 18.61M 16.77M - -
Short long term debt total 75.00M 34.36M 17.64M - -
Other stockholder equity 463.82M 67.65M 66.58M 77.76M 61.31M
Property plant equipment - - - 57.10M 58.86M
Total current assets 477.72M 429.13M 391.57M 385.89M 306.50M
Net tangible assets - - - 328.03M 275.88M
Net receivables 104.50M 83.77M 74.30M 101.66M 68.63M
Inventory 161.13M 160.52M 145.39M 114.33M 97.41M
Accounts payable - 17.73M 25.08M 24.47M 13.21M
Accumulated other comprehensive income - 35.58M 19.39M - -
Non currrent assets other 9.22M - 31.25M -87.38M -89.03M
Non current assets total 182.88M 145.84M 114.15M 87.38M 89.03M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - 0.00M -0.32M
Total cashflows from investing activities -36.00M -24.69M -29.73M -21.10M -11.49M
Net borrowings - - - -7.31M -12.00M
Total cash from financing activities -122.69M -91.53M -84.88M -70.30M -59.05M
Change to operating activities - - - - 0.20M
Net income 159.21M 103.83M 103.82M 113.97M 90.90M
Change in cash 32.88M 25.34M 1.23M 23.15M 57.60M
Begin period cash flow 179.21M 153.87M 152.64M 129.49M 71.89M
End period cash flow 212.09M 179.21M 153.87M 152.64M 129.49M
Total cash from operating activities 191.57M 143.10M 113.19M 113.49M 127.37M
Depreciation 24.83M 24.51M 23.66M 23.29M 23.43M
Other cashflows from investing activities -36.00M - -13.33M -21.10M -11.49M
Dividends paid 109.47M 82.41M 82.18M 68.40M 54.64M
Change to inventory - -15.13M -31.06M -16.92M 15.25M
Change to account receivables - 5.32M 27.35M -33.02M -11.15M
Sale purchase of stock -4.41M - - - -
Other cashflows from financing activities -8.81M - 6.01M 5.40M 7.59M
Change to netincome - - - -22.70M 9.83M
Capital expenditures 191.57M 6.07M 29.73M 9.25M 7.40M
Change in working capital -6.83M 12.75M -20.59M -49.94M 4.11M
Other non cash items 14.37M 2.01M 6.30M 26.17M 8.94M
Free cash flow - 137.04M 83.46M 104.24M 119.97M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0OCD
Medistim ASA		 6.00
2.00%		 306.00 0.44 - 6.14 -
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Oekernveien 94, Oslo, Norway, 0579

47 23 05 96 60

https://www.medistim.com

154

Name Title Year Born
Ms. Kari Eian Krogstad CEO & Pres 1964
Mr. Thomas Jakobsen Chief Financial Officer 1969
Mr. Helge Borslid VP of Operations & Manufacturing NA
Ms. Hæge Johanne Krogh Wetterhus VP of Marketing 1964
Mr. Roger Reino Morberg VP of Sales 1964
Mr. Hakon Grothe Chief Innovation Officer NA
Mr. Ole Jorgen Robsrud CEO of Medistim Norge AS & MD of Medistim Norge AS NA
Mr. Mike Farbelow Pres of Medistim USA Inc NA
Cindy Kaffai Country Mang. of Medistim Deutschland GmbH NA
Mr. Ole Arne Eiksund Chief Bus. Devel. Officer 1967

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ORE
CAD 2.77
+8.86%
APM
CAD 4.95
+8.08%
NUAG
CAD 7.37
+8.06%
BZ
CAD 4.03
+8.04%
AYA
CAD 34.85
+7.96%
HUT
CAD 73.56
-17.26%
PHX
CAD 11.13
-12.22%
IVN
CAD 7.93
-10.70%
EFN
CAD 20.09
-10.39%
OBE
CAD 13.62
-6.71%

Equity Sectors*

  • Basic Materials

    +3.73%

  • Communication Services

    +1.16%

  • Consumer Cyclical

    +1.12%

  • Consumer Defensive

    +0.14%

  • Energy

    -1.87%

  • Financial Services

    +1.53%

  • Healthcare

    +1.50%

  • Industrials

    +0.03%

  • Real Estate

    +0.71%

  • Technology

    +0.40%

  • Utilities

    +0.35%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…